Our current study sample (sedentary, older, overweight or obese women) are at high risk for cardiovascular disease and for type 2 diabetes and its complications; thus, any method that improves postprandial glucose and insulin responses in this population could have clinically meaningful results if practiced regularly. The gene discussed is INS; the disease is cardiovascular disorder.